The first start-up project supported by the Springboard facility at Paris Biotech Santé was launched on May 24, 2022. It aims to improve preoperative planning for pediatric tumors and malformations, in order to achieve a higher level of safety and efficacy and lower morbidity. This project is currently focused on pelvic tumors and malformations, but aims to expand to all pediatric surgical specialties represented at Necker-Enfants malades Hospital. Do not hesitate to support projects like this one through the Springboard program.